S-Tsuchiya K, Arita M, Hori M, Otani T
Showa College of Pharmaceutical Sciences, Tokyo, Japan.
J Antibiot (Tokyo). 1994 Jul;47(7):787-91. doi: 10.7164/antibiotics.47.787.
A monoclonal antibody raised against C-1027 apoprotein recognized not only the apoprotein, but also the holoantibiotic (Antibiotic C-1027) almost equally. Among the biochemical and biological activities of the holoantibiotic, the antibody inhibited the aminopeptidase activity and the cytotoxicity to Ehrlich carcinoma cells in cultures, but not the DNA-cleaving activity in vitro. The immunohistogram, using this antibody, of Ehrlich carcinoma cells that had been exposed to the holoantibiotic suggested penetration of the holoantibiotic into target cells.
一种针对C-1027脱辅基蛋白产生的单克隆抗体不仅能识别脱辅基蛋白,而且对全抗生素(抗生素C-1027)的识别能力几乎相同。在全抗生素的生化和生物学活性中,该抗体抑制培养物中的氨肽酶活性以及对艾氏癌细胞的细胞毒性,但不抑制体外DNA切割活性。使用这种抗体对暴露于全抗生素的艾氏癌细胞进行免疫组化分析表明,全抗生素可穿透靶细胞。